Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease

06.12.2022 - Pfizer Inc. (NYSE: PFE) and Clear Creek Bio, Inc. today announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the SARS-CoV-2 papain-like protease (PLpro) for the oral ... Seite 1

Related Keywords

Vikram Sheel Kumar ,Charlotte Allerton ,Pfizer ,Chief Scientific ,Medicine Design ,Chief Executive Officer ,Clear Creek ,Creek Bio ,